Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06378944

Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

Sponsor: Omphis Foundation

View on ClinicalTrials.gov

Summary

The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.

Official title: INDOCYANINE GREEN for SELECTIVE SENTINELLA AXILLARY LYMPH NODE BIOPSY in PATIENTS with BREAST CANCER

Key Details

Gender

All

Age Range

18 Years - 120 Years

Study Type

OBSERVATIONAL

Enrollment

15000

Start Date

2024-01-01

Completion Date

2029-01-01

Last Updated

2024-09-19

Healthy Volunteers

No

Conditions

Interventions

OTHER

Application of green indocyanine colorant

The day of the surgery 1 ml of green indocyanine colorant will be applicated periareolar. After 5 minutes the lymph node will be detected and extracted

DRUG

Technetium99

Application of a periareolar injectionof TEchnetium 99 in order to detect the axillary lymph node

Locations (1)

Sandra Lopez Gordo

Cerdanyola del Vallès, Barcelona, Spain